Blog - Page 530 of 5683 - QualityStocks

FridayMar 15, 2024 3:16 pm

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Poised for Opportunity in Burgeoning Indian Market

GEMXX (OTC: GEMZ), a leading mine-to-market company focused on mining and producing jewelry out of gold and ammolite, recently provided a positive outlook covering India’s burgeoning markets for colored gemstones and jewelry. “In the press release, GEMXX highlighted recent industry forecasts, which anticipate that the jewelry market in India will surge by US$21.54 billion between 2023 and 2027, representing an impressive CAGR of 5.54%. This growth, GEMXX holds, is positioning India as a key player in the global jewelry arena. The company also singled out the colored gemstones market in India, which analysts expect to reach US$707.8 million in 2024…

FridayMar 15, 2024 2:01 pm

QualityStocksNewsBreaks – Astiva Health Addressing Challenges of Traditional Caregiving Structures

Astiva Health is a leading healthcare provider that specializes in delivering personalized and comprehensive solutions to diverse communities. The company is leading the charge in creating essential healthcare solutions tailored for the expanding aging Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the population requiring more support. “The company is proactively meeting the unique needs of this group by providing healthcare services that are culturally sensitive and honor the diverse traditions and values across Asian cultures… Astiva Health’s commitment to culturally sensitive care acknowledges the importance of traditional values such as filial piety…

FridayMar 15, 2024 1:08 pm

QualityStocksNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Filling Gap in Therapeutic Antibody Treatment Space

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, is currently focused on the development of four therapeutic candidates to address clearly defined limitations in global health. These include the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic antibodies to treat cancer, ChemoPrep(TM) to enhance the targeted delivery of chemotherapy, ChemoPure(TM) to reduce the toxicity of chemotherapy, and Sigyn Therapy(TM) to address pathogen-associated conditions that are beyond the reach of drugs. “Though highly valued, [immunotherapeutic antibodies to treat cancer] are limited by poor delivery to cancer cell targets and as a result, most patients do not respond to therapy. Inhibiting…

FridayMar 15, 2024 12:46 pm

QualityStocksNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Well Positioned to Capitalize on World’s Ongoing Energy Transition

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Canadian natural resource exploration and development company, is keen on targeting high-grade nickel sulfide developments for use in the rapidly growing electric vehicle market. “Led by a management team boasting over 100 years of combined mining and exploration experience and having raised gross proceeds of approximately C$7.5 million over the past six months to fund its incremental exploration work, Fathom Nickel has set its sights on developing two key nickel projects – the Albert Lake and Gochager Lake projects,” a recent article reads. “With total EV sales anticipated to swell from…

FridayMar 15, 2024 11:51 am

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Is Expanding Global Reach with Innovative Products

SenesTech (NASDAQ: SNES) is dramatically improving pest management technicians’ toolboxes with its patent-pending Evolve(R) soft bait birth control product for rodents, which joins the liquid ContraPest(TM) product in providing non-lethal solutions to reducing rodent populations. “The patent-pending Evolve(TM) soft bait has a sausage-like appearance and poses little or no risk to human health or the environment – a significant advantage over poisons used to kill rats. SenesTech’s products are the first, and still the only, such rat contraceptives registered with the U.S. Environmental Protection Agency (‘EPA’) that target both male and female rats… The company recommends using its Birth Control…

FridayMar 15, 2024 11:33 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced the publication of peer-reviewed research, titled “Protein Corona Composition of Gold Nanocrystals.” The publication appeared in the journal ACS Pharmacology & Translational Science and fully characterized the proteins from human blood plasma that form the protein corona of the gold nanocrystals of CNM-Au8(R), Clene’s investigational drug in development for the treatment of neurodegenerative diseases. “The protein corona of CNM-Au8 gold nanocrystals, tailored for brain delivery…

FridayMar 15, 2024 9:45 am

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Advances Exploration Program, Closes Private Placement

The Canadian Shield hosts numerous nickel, copper, gold, and platinum group metals Fathom targets high-grade nickel sulfide discoveries for use in EV and green energy markets Fathom operates the Albert Lake Project and the Gochager Lake Project, both located in Saskatchewan's Trans Hudson Corridor Favorable results revealed from recent drilling at the Albert Lake Project Company recently closed the second and final tranche of its non-brokered offering, total gross proceeds totaled $4,571,063 when combined with the first tranche The Canadian Shield’s rich mineral endowment presents abundant mining exploration and drilling opportunities. Covering a significant portion of Canada, this vast geological…

FridayMar 15, 2024 9:00 am

Turbo Energy (NASDAQ: TURB) Aligned with Rising EU and U.S. Renewable Energy Targets

EU raised 2030 binding renewable energy target to a minimum of 42.5%, aims to become climate-neutral by 2050 U.S. set goal of 100% clean energy by 2035 TURB aligned with renewable energy shift with Sunbox Home and Sunbox Industry TURB’s all-in-one systems leverage AI to improve efficiency, prevent price shocks, and maximize cost savings Turbo Community allows members with large PV installations to gain ownership of production, store extra power, and sell energy to market The European Union recently raised its 2030 binding renewable target to a minimum of 42.5% with the aim of reaching 45% and becoming a climate-neutral…

ThursdayMar 14, 2024 3:45 pm

QualityStocksNewsBreaks – Software Effective Solutions Corp. (SFWJ) Moving to Become World’s Premier Resource for High-Quality Pharmaceutical Products

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) has established five companies focused on pharmaceutical cannabis production, managing processes for plant-to-patient operations, and irrigation and greenhouse technology. “A global infrastructure and holding company in the cannabis industry, MedCana is on a mission to become the world’s premier resource for pharmaceutical cannabis products,” reads a recent article that discusses the burgeoning global medical marijuana market and the increasing trend of cannabis decriminalization around the world. “With this backdrop of growing awareness and acceptance of medical cannabis, MedCana is well positioned to become an industry leader. The company has assembled a team of…

ThursdayMar 14, 2024 3:02 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as senior vice president of finance and operations at Rain Oncology Inc., a late-stage precision oncology biotech company. In that position, he was pivotal in building and leading the company’s financial organization, resulting in significant growth…

Site Search

Company Search